S. Hendrix

发表

Frequency and predictive value of a mammographic recommendation for short-interval follow-up.

J. Robbins, R. Chlebowski, P. Romano, 2003, Journal of the National Cancer Institute.

Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.

Robert B. Wallace, Claudine Legault, Stephen R. Rapp, 2003 .

Influence of Estrogen Plus Progestin on Breast Cancer and Mammography in Healthy Postmenopausal Women: The Women's Health Initiative Randomized Trial

R. Langer, A. McTiernan, R. Chlebowski, 2003 .

Progression and remission of pelvic organ prolapse: a longitudinal study of menopausal women.

E. Garrett, E. Gold, S. Hendrix, 2004, American journal of obstetrics and gynecology.

Tibolone histology of the endometrium and breast endpoints study: design of the trial and endometrial histology at baseline in postmenopausal women.

A. Ferenczy, W. den Hollander, D. Archer, 2007, Fertility and sterility.

National cross sectional survey to determine whether the decision to delivery interval is critical in emergency caesarean section

John Robbins, Lawrence Phillips, Bette Caan, 2004, BMJ : British Medical Journal.

Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial.

C. Kooperberg, W. Mysiw, H. Black, 2003, JAMA.

Operative vaginal delivery and midline episiotomy: a bad combination for the perineum.

R. Sokol, S. Blackwell, M. Kruger, 2006, American journal of obstetrics and gynecology.

Factors associated with anal sphincter laceration in 40,923 primiparous women

S. Hendrix, A. Hammoud, B. Kudish, 2007, International Urogynecology Journal.

Long-term use of hormone therapy for urogenital complaints: is there a role?

S. Hendrix, 2003, The Medical clinics of North America.

Hormone therapy: evolving concepts

S. Hendrix, 2003, Current opinion in rheumatology.

Endometrial effects of tibolone.

A. Ferenczy, W. den Hollander, D. Archer, 2007, The Journal of clinical endocrinology and metabolism.

Estrogen Receptor Polymorphisms and the Vascular Effects of Hormone Therapy

C. Kooperberg, J. Hsia, G. Papanicolaou, 2011, Arteriosclerosis, thrombosis, and vascular biology.

Quality of life in MAP.3 (Mammary Prevention 3): a randomized, placebo-controlled trial evaluating exemestane for prevention of breast cancer.

K. Gelmon, R. Chlebowski, M. Brundage, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Estrogen and Heart Disease: Alternatives to a Paradigm in Crisis—Reply

J. Manson, S. Crawford, Karen C Johnson, 2006 .

Lipoprotein Particle Concentrations May Explain the Absence of Coronary Protection in the Women's Health Initiative Hormone Trials

Jennifer G. Robinson, J. Hsia, L. Kuller, 2008, Arteriosclerosis, thrombosis, and vascular biology.

Alcohol and folate consumption and risk of benign proliferative epithelial disorders of the breast

R. Chlebowski, T. Rohan, D. Page, 2007, International journal of cancer.

Relation of demographic factors, menstrual history, reproduction and medication use to sex hormone levels in postmenopausal women

C. Y. Wang, A. McTiernan, T. Rohan, 2008, Breast Cancer Research and Treatment.

Hormone Use, Reproductive History, and Risk of Lung Cancer: The Women’s Health Initiative Studies

J. Manson, C. Kooperberg, H. Wakelee, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Menopausal symptom experience before and after stopping estrogen therapy in the Women's Health Initiative randomized, placebo-controlled trial

J. Ockene, N. Woods, M. Stefanick, 2010, Menopause.

Effects of estrogen with and without progestin on urinary incontinence.

R. Wallace, M. Naughton, A. Aragaki, 2005, JAMA.

Bilateral oophorectomy and premature menopause.

S. Hendrix, 2005, The American journal of medicine.

Douching and Endometritis: Results From the PID Evaluation and Clinical Health (PEACH) Study

R. Ness, R. Sweet, S. Hillier, 2001, Sexually transmitted diseases.

Douching and Endometritis

S. Hillier, S. Hendrix, S. Sondheimer, 2001 .

An assessment of the value of ultrasonographic screening for endometrial disease in postmenopausal women without symptoms.

A. Fleischer, J. Wheeler, S. Hendrix, 2001, American journal of obstetrics and gynecology.

Effect of Selective Estrogen Receptor Modulators on Reproductive Tissues Other Than Endometrium

S. Hendrix, S. Mcneeley, 2001, Annals of the New York Academy of Sciences.

Reanalysis of the Women's Health Initiative oral contraceptive data reveals no evidence of delayed cardiovascular benefit.

J. Manson, R. Prentice, G. Anderson, 2005, Fertility and sterility.

Sleep Complaints of Postmenopausal Women.

D. Kripke, R. Jackson, K. Masaki, 2001, Clinical journal of women's health.

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial.

R. Langer, A. McTiernan, R. Chlebowski, 2003, JAMA.

Use of electric blankets and association with prevalence of endometrial cancer

Susan R. Johnson, Y. Mossavar-Rahmani, M. Kruger, 2007, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial.

J. Manson, A. LaCroix, R. Langer, 2006, JAMA.

A new image.

S. Hendrix, 2003, American journal of obstetrics and gynecology.

Restingheartrateasalowtechpredictorofcoronaryevents in women: prospective cohort study

Jennifer G. Robinson, J. Manson, A. LaCroix, 2009 .

Update in Women's Health

J. Grisso, R. Ness, S. Hendrix, 1997, Annals of Internal Medicine.

Primary and preventive care in a university obstetrics and gynecology group practice.

S. Hendrix, S. Mcneeley, S. Piereson, 1995, American journal of obstetrics and gynecology.

Calcium plus vitamin D supplementation and the risk of colorectal cancer.

John Robbins, Thomas E Rohan, Lewis H Kuller, 2006, The New England journal of medicine.

Urinary incontinence and menopause: an evidence-based treatment approach.

S. Hendrix, 2002, Disease-a-month : DM.

Gynecologic and Urogynecologic Aspects of Menopause

V. Pinn, P. Crosignani, S. Hendrix, 2002 .

Prior oral contraception and postmenopausal fracture: a Women's Health Initiative observational cohort study.

C. Kooperberg, N. Watts, J. Wactawski‐Wende, 2005, Fertility and sterility.

Re: Short-interval follow-up mammography: are we doing the right thing?

J. Robbins, R. Chlebowski, P. Romano, 2003, Journal of the National Cancer Institute.

Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial.

C. Kooperberg, W. Mysiw, H. Black, 2003, JAMA.

Effects of Conjugated Equine Estrogen on Stroke in the Women’s Health Initiative

J. Buring, C. Kooperberg, B. Howard, 2006, Circulation.

Adverse cardiovascular disease outcomes are reduced in women with a history of oral contraceptive use: Results from the Women’s Health Initiative Database

R. Victory, M. Diamond, S. Hendrix, 2004 .

Primary dysmenorrhea treatment with a desogestrel-containing low-dose oral contraceptive.

S. Hendrix, N. Alexander, 2002, Contraception.

Calcium/vitamin D supplementation and coronary artery calcification in the Women's Health Initiative

Jennifer G. Robinson, J. Manson, R. Langer, 2010, Menopause.

Calcium plus vitamin D supplementation and the risk of fractures.

J. Manson, A. LaCroix, S. Cummings, 2006, The New England journal of medicine.

Calcium plus vitamin D supplementation and the risk of fractures: Commentary

J. Manson, A. LaCroix, S. Cummings, 2006 .

Estrogen alone in postmenopausal women and breast cancer detection by means of mammography and breast biopsy.

J. Manson, R. Langer, G. Anderson, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The legendary superior strength of the Pfannenstiel incision: a myth?

A. Singh, S. Hendrix, J. Martín, 2000, American journal of obstetrics and gynecology.

Synthetic graft placement in the treatment of fascial dehiscence with necrosis and infection.

S. Ransom, S. M. Bennett, A. Singh, 1998, American journal of obstetrics and gynecology.

Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study

L. Thal, C. Lewis, L. Kuller, 2004, JAMA.

Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.

Robert B Wallace, Claudine Legault, Sylvia Wassertheil-Smoller, 2003, JAMA.

Endometritis does not predict reproductive morbidity after pelvic inflammatory disease.

J. Peipert, R. Ness, R. Sweet, 2003, American journal of obstetrics and gynecology.

Pelvic organ prolapse in the Women's Health Initiative: gravity and gravidity.

A. McTiernan, A. Aragaki, V. Barnabei, 2002, American journal of obstetrics and gynecology.

Effect of Weight Change on Natural History of Pelvic Organ Prolapse

B. Howard, R. Sokol, H. Richter, 2009, Obstetrics and gynecology.

Cardiovascular disease, its risk factors and treatment, and age-related macular degeneration: Women's Health Initiative Sight Exam ancillary study.

R. Klein, B. Klein, R. Langer, 2007, American journal of ophthalmology.

Design of the PID Evaluation and Clinical Health (PEACH) Study.

J. Lave, J. Peipert, S. Kelsey, 1998, Controlled clinical trials.

Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women.

J. Manson, R. Prentice, L. Kuller, 2010, JAMA.

Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy.

Garnet L Anderson, Shagufta Yasmeen, G. Anderson, 2006, JAMA.

Medroxyprogesterone acetate treatment of abnormal uterine bleeding: factors predicting satisfaction.

A. Washington, H. Richter, F. Lin, 2003, American journal of obstetrics and gynecology.

Transvaginal ultrasound-guided aspiration of pelvic abscesses.

M. Diamond, S. Hendrix, B. Gonik, 1999, Infectious diseases in obstetrics and gynecology.

Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial.

J. Lave, J. Peipert, S. Kelsey, 2002, American journal of obstetrics and gynecology.

Predictors of Chronic Pelvic Pain in an Urban Population of Women With Symptoms and Signs of Pelvic Inflammatory Disease

J. Peipert, S. Weitzen, R. Ness, 2005, Sexually transmitted diseases.

Clinical predictors of endometritis in women with symptoms and signs of pelvic inflammatory disease.

J. Peipert, R. Ness, J. Blume, 2001, American journal of obstetrics and gynecology.

Medically sound, cost-effective treatment for pelvic inflammatory disease and tuboovarian abscess.

S. Ransom, S. Hendrix, D. Kmak, 1998, American journal of obstetrics and gynecology.

The Women's Health Initiative Observational Study: baseline characteristics of participants and reliability of baseline measures.

R. Langer, C. Lewis, M. Trevisan, 2003, Annals of epidemiology.

Condom use and the risk of recurrent pelvic inflammatory disease, chronic pelvic pain, or infertility following an episode of pelvic inflammatory disease.

J. Peipert, R. Ness, H. Richter, 2004, American journal of public health.

Hormone therapy increased incidence and severity of urinary incontinence in healthy postmenopausal women

S. Hendrix, 沈平虎, 2006 .

Prevalence and correlates of panic attacks in postmenopausal women: results from an ancillary study to the Women's Health Initiative.

J. Smoller, M. Pollack, B. Barton, 2003, Archives of internal medicine.

Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study.

Lewis H Kuller, Charles Kooperberg, Garnet L Anderson, 2008, American journal of epidemiology.

Estrogen plus progestin therapy and breast cancer in recently postmenopausal women.

Lewis H Kuller, Charles Kooperberg, Garnet L Anderson, 2008, American journal of epidemiology.

Oral bisphosphonate use and breast cancer incidence in postmenopausal women.

J. Manson, J. Cauley, G. Anderson, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial.

J. Manson, A. LaCroix, R. Langer, 2006, JAMA.

Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial.

J. Manson, A. LaCroix, R. Langer, 2006, JAMA.

1. ACCF/AHA. (2007). Clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain. Circulation, 115, 402-

J. Hsia, L. Kuller, G. Anderson, 2011 .

Low-fat, increased fruit, vegetable, and grain dietary pattern, fractures, and bone mineral density: the Women's Health Initiative Dietary Modification Trial.

F. Tylavsky, A. McTiernan, N. Watts, 2009, The American journal of clinical nutrition.

Oophorectomy, hormone therapy, and subclinical coronary artery disease in women with hysterectomy: the Women's Health Initiative coronary artery calcium study

Jennifer G. Robinson, J. Manson, R. Langer, 2008, Menopause.

Breast cancer after use of estrogen plus progestin in postmenopausal women.

J. Manson, R. Prentice, L. Kuller, 2009, The New England journal of medicine.

Inflammatory, lipid, thrombotic, and genetic markers of coronary heart disease risk in the women's health initiative trials of hormone therapy.

Jennifer G. Robinson, Mary Cushman, Charles Kooperberg, 2008, Archives of internal medicine.

Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative.

Charles B Eaton, J. Manson, R. Langer, 2006, Archives of internal medicine.

Baseline associations between postmenopausal hormone therapy and inflammatory, haemostatic, and lipid biomarkers of coronary heart disease

J. Manson, A. LaCroix, P. Ridker, 2005, Thrombosis and Haemostasis.

Resting heart rate as a low tech predictor of coronary events in women: prospective cohort study

Jennifer G. Robinson, J. Manson, A. LaCroix, 2009, BMJ : British Medical Journal.

Hormonal and barrier contraception and risk of upper genital tract disease in the PID Evaluation and Clinical Health (PEACH) study.

J. Peipert, S. Kelsey, R. Ness, 2001, American journal of obstetrics and gynecology.

Cross‐Sectional Geometry, Bone Strength, and Bone Mass in the Proximal Femur in Black and White Postmenopausal Women

D. A. Barondess, T. Beck, D. Nelson, 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

238: Factors affecting patient preferences for mode of delivery

R. Sokol, S. Hendrix, B. Kudish, 2007 .

Postmenopausal Cardiovascular Risk Lipoprotein-Associated Phospholipase A 2, Hormone Use, and the Risk of Ischemic Stroke in Postmenopausal Women

J. Manson, C. Kooperberg, J. Hsia, 2022 .

Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.

G. Anderson, A. McTiernan, K. Margolis, 2006, Maturitas.

Cross‐sectional correlates of fasting hyperinsulinaemia in post‐menopausal women of different ethnic origin

L. Wagenknecht, N. Cook, A. Pradhan, 2006, Diabetic medicine : a journal of the British Diabetic Association.

Validation of a Two-Item Quantitative Questionnaire for the Triage of Women With Urinary Incontinence

S. Hendrix, A. Bent, A. Gousse, 2005, Obstetrics and gynecology.

Inflammation and hemostasis biomarkers for predicting stroke in postmenopausal women: the Women's Health Initiative Observational Study.

Charles Kooperberg, Alison E Baird, Sylvia Wassertheil-Smoller, 2008, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Panic Attacks, Daily Life Ischemia, and Chest Pain in Postmenopausal Women

J. Hsia, J. Smoller, M. Pollack, 2006, Psychosomatic medicine.

Oral Bisphosphonate and Breast Cancer: Prospective Results from the Women's Health Initiative (WHI).

J. Cauley, A. McTiernan, L. Snetselaar, 2009 .

New-onset breast tenderness after initiation of estrogen plus progestin therapy and breast cancer risk.

L. Kuller, J. Cauley, G. Anderson, 2009, Archives of internal medicine.

Conjugated equine estrogens and coronary heart disease : The women's health initiative

J. Manson, R. Langer, S. Crawford, 2006 .

Oral pilocarpine to treat vaginal xerosis associated with chemotherapy-induced amenorrhea in pre-menopausal women.

S. Hendrix, F. G. Le Veque, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Nonestrogen management of menopausal symptoms.

S. Hendrix, 1997, Endocrinology and metabolism clinics of North America.